Hellstrom et al., Cancer Res. 45:2210-2218 (1985). |
Flood et al., Proc. Natl. Acad. Sci. U.S.A. 77:2209-2213 (1980). |
Binz et al., Int. J. Cancer 29:417-423 (1982). |
Forstrom et al., Nature (London) 303:627-629 (1983). |
Nepom et al., Proc. Natl. Acad. Sci. U.S.A. 81:2864-2867 (1984). |
Holbeck and Nepom, J. Immunol. Methods 60:47-52 (1983). |
Chapman, J. Urol. 88:518-526 (1962). |
Halliday and Maluish InAssessment of Immune Status by the Leukocyte Adherence Inhibition Test, Thomson, ed., Academic, New York, pp. 1-26 (1982). |
Koppi and Halliday, Cell. Immunol. 66:394-406 (1982). |
Koppi and Halliday, J. Natl. Cancer Inst. 66:1089-1096 (1981). |
Binz and Wigzell, J. Exp. Med. 142:197-211 (1975). |
Hellstrom and Hellstrom, Adv. Cancer Res. 12:167-223 (1969). |
Brawn, Int. J. Cancer 6:245-249 (1970). |
Hellstrom et al., Int. J. Cancer 6:346-351 (1970). |
Taranger et al., Science 176:1337-1340 (1972). |
Halliday, et al., Cell. Immunol. 10:467-475 (1974). |
Heberman, Ad. Cancer Res. 19:207-263 (1974). |
Steele et al., J. Natl. Cancer Inst. 54:959-967 (1975). |
Halliday, et al., Int. J. Cancer 16:645-658 (1975). |
Thomson, Cancer Res/ 39:627-629 (1979). |
Hellstrom et al., In Springer Seminars in Immunopathology: Mechanism of Host Resistance in Cancer, Baldwin, ed., Springer-Verlag, New York, pp. 127-146 (1982). |
Hellstrom et al., Int. J. Cancer 29:175-180 (1982). |